How diet carbs affect GVHD after bone marrow transplant
Part of Immune system & allergy clinical trials.
This study looks at whether certain types of gut carbohydrates (called FODMAPs) are linked to graft-versus-host disease (GVHD) after a bone marrow transplant. It may help doctors understand how diet could influence symptoms and outcomes for people with specific blood cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these blood conditions: AML, ALL, MDS, or multiple myeloma (MM)
- You are being treated with a bone marrow transplant
- Your transplanted marrow has successfully started working (“engrafted”)
- You do not have a significant gastrointestinal (stomach/intestine) disease
- Your age is between 10 and 60 years old
- You did not take probiotics or prebiotics before joining the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune cells in the blood and tissues of people who have had a stem cell transplant. It aims to understand chronic graft-versus-host disease (GVHD), a common complication, so doctors can better detect and treat it.
This study tests whether a fecal transplant (FMT) can help treat gut graft-versus-host disease (gut GVHD), a condition where donated immune cells attack the intestines. If you have gut GVHD and meet age requirements, you may be eligible to receive this treatment in the trial.
This trial studies a treatment made from donor gut microbes to help prevent a common complication after a transplant called acute graft-versus-host disease (aGVHD). It may help by improving the balance and variety of gut bacteria during recovery after haploidentical transplant.
This Phase 1 study tests whether a fecal microbiota transplant (a stool-based treatment from a screened donor) plus a dietary fiber supplement can improve gut symptoms after a bone marrow transplant. It is aimed at people with mild to severe gut graft-versus-host disease (GVHD).
This early-phase study tests a prebiotic (galacto-oligosaccharide) to see if it can lower or prevent gut inflammation caused by acute graft-versus-host disease (acute GVHD) after a stem cell transplant. If you’re scheduled for an allogeneic transplant, participating may help researchers find safer ways to protect your gut.
This trial tests whether a special probiotic made from the patient's own gut bacteria and their donor's can help fix gut problems caused by a complication called graft-versus-host disease (aGVHD) after a stem cell transplant. It might help patients who are over 50 and scheduled for a specific type of transplant.
Hear when a new Graft Versus Host Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.